News
Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study
A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy. The study — published May 11 in the New England Journal of Medicine — followed 751 people across the U.
Hosted on MSN11mon
Novo Nordisk blames middlemen in U.S. healthcare system for high prices of weight loss drugs Wegovy and OzempicNovo Nordisk has blamed middlemen in the U.S. healthcare system for the high prices of its top-selling weight-loss drugs Wegovy and Ozempic, following the launch of an investigation into ...
Generic versions of Ozempic, Wegovy, and Mounjaro flooded into the market via med spas and ... provide brand-name drugs at a more accessible price, but the profits they made from manufacturing ...
The pharmaceutical company that makes the weight-loss drug Wegovy and the diabetes medication Ozempic secured a court victory that limits compounding pharmacies from selling versions of those ...
Analysts and investors had long understood that Ozempic and Wegovy would appear on the list of drugs with negotiated ...
Hims & Hers Health, Inc. teams up with Novo Nordisk to offer Wegovy at $599/month, slashing costs. Click for why this is a ...
Bernie Sanders is taking aim at the high prices ... Wegovy. The Vermont senator, an independent who has long called out drug manufacturers for their costly products, is launching an ...
Ozempic/Wegovy is the first drug on HHS's 2025 list of Medicare price negotiations. As the leaders of the pharmaceutical industry boarded their planes to come home from the JP Morgan Healthcare ...
Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare's list of medications that will be negotiated directly between the government and drug manufacturers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results